Related references
Note: Only part of the references are listed.Obesity and the Obesity Paradox in Heart Failure
Adrienne L. Clark et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2014)
Angiotensin-converting enzyme inhibition and food restriction restore delayed preconditioning in diabetic mice
Gerry Van der Mieren et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Obesity improves myocardial ischaemic tolerance and RISK signalling in insulin-insensitive rats
Daniel Donner et al.
DISEASE MODELS & MECHANISMS (2013)
Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance
I. Wensley et al.
EXPERIMENTAL PHYSIOLOGY (2013)
Decreased long-chain fatty acid oxidation impairs postischemic recovery of the insulin-resistant rat heart
Romain Harmancey et al.
FASEB JOURNAL (2013)
Hexokinase cellular trafficking in ischemia-reperfusion and ischemic preconditioning is altered in type I diabetic heart
Ebru Gurel et al.
MOLECULAR BIOLOGY REPORTS (2013)
Effects of Coronary Ischemia-Reperfusion in a Rat Model of Early Overnutrition. Role of Angiotensin Receptors
Miriam Granado et al.
PLOS ONE (2013)
The Bitter Fate of the Sweet Heart: Impairment of Iron Homeostasis in Diabetic Heart Leads to Failure in Myocardial Protection by Preconditioning
Vladimir Vinokur et al.
PLOS ONE (2013)
The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation
Ruduwaan Salie et al.
BASIC RESEARCH IN CARDIOLOGY (2012)
Angiotensin-converting enzyme inhibition and food restriction in diabetic mice do not correct the increased sensitivity for ischemia-reperfusion injury
Gerry Van der Mieren et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning
Takayuki Miki et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Effect of Chronic CPT-1 Inhibition on Myocardial Ischemia-Reperfusion Injury (I/R) in a Model of Diet-Induced Obesity
Gerald Maarman et al.
CARDIOVASCULAR DRUGS AND THERAPY (2012)
Healing the diabetic heart: Does myocardial preconditioning work?
Pitchai Balakumar et al.
CELLULAR SIGNALLING (2012)
Pharmacological Preconditioning in Type 2 Diabetic Rat Hearts: The Roles of Mitochondrial ATP-Sensitive Potassium Channels and the Phosphatidylinositol 3-Kinase-Akt Pathway
Shuhei Matsumoto et al.
CARDIOVASCULAR DRUGS AND THERAPY (2009)
The impairment of preconditioning-mediated cardioprotection in pathological conditions
Pitchai Balakumar et al.
PHARMACOLOGICAL RESEARCH (2009)
Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice
Omar Bouhidel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Myocardial susceptibility to ischemic-reperfusion injury in a prediabetic model of dietary-induced obesity
Eugene F. du Toit et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Increased Myocardial Susceptibility to Repetitive Ischemia With High-fat diet-induced Obesity
Geeta D. Thakker et al.
OBESITY (2008)
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection
Derek J. Hausenloy et al.
HEART FAILURE REVIEWS (2007)
Western diet, but not high fat diet, causes derangements of fatty acid metabolism and contractile dysfunction in the heart of Wistar rats
Christopher R. Wilson et al.
BIOCHEMICAL JOURNAL (2007)
Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance
Prasad V. G. Katakam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Protection against myocardial ischemia/reperfusion injury by short-term diabetes: enhancement of VEGF formation, capillary density, and activation of cell survival signaling
Guochuan Ma et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
The obesity paradox in non-ST-segment elevation acute coronary syndromes: Results from the can rapid risk stratification of unstable angina patients suppress ADverse outcomes with early implementation of the American College of Cardiology/American Heart Association guidelines quality improvement initiative
Deborah B. Diercks et al.
AMERICAN HEART JOURNAL (2006)
Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity
J Buchanan et al.
ENDOCRINOLOGY (2005)
Preconditioning the diabetic heart - The importance of Akt phosphorylation
A Tsang et al.
DIABETES (2005)
A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury
EF du Toit et al.
BASIC RESEARCH IN CARDIOLOGY (2005)
Ischemic preconditioning protects by activating prosurvival kinases at reperfusion
DJ Hausenloy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Contradictory effects of short- and long-term hyperglycemias on ischemic injury of myocardium via intracellular signaling pathway
G Xu et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2004)
Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts
PK Mazumder et al.
DIABETES (2004)
Ischaemic preconditioning does not protect the heart in obese and lean animal models of Type 2 diabetes
SB Kristiansen et al.
DIABETOLOGIA (2004)
Ischemic preconditioning: Infarct size is a more reliable endpoint than functional recovery
A Lochner et al.
BASIC RESEARCH IN CARDIOLOGY (2003)
Mitogen-activated protein kinases in the acute diabetic myocardium
M Strniskova et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Protein kinase B in the diabetic heart
B Huisamen
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Effect of acute hyperglycaemia and diabetes mellitus with and without short-term insulin treatment on myocardial ischaemic late preconditioning in the rabbit heart in vivo
D Ebel et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2003)
Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1
R Marfella et al.
DIABETOLOGIA (2002)
Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the Zucker fatty rat heart
RJ Sidell et al.
DIABETES (2002)
Share Paper
